Enanta Pharmaceuticals Long Term Deferred Charges (Quarterly) Trends

Enanta Pharmaceuticals, Inc. (ENTA)

13.51 -0.49 (-3.50%) USD | NASDAQ | Feb 20, 16:00

13.65 +0.14 (+1.04%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for ENTA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Agios Pharmaceuticals, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--